AVE 50.0% 0.3¢ avecho biotechnology limited

Looks like there is some competition out there for the shingles...

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 427 Posts.
    lightbulb Created with Sketch. 32
    Looks like there is some competition out there for the shingles relief market. I came across this recruitment advert while reading some news on the mobile phone.

    https://www.shinglesclinicalstudy.com/Index.aspx

    This is a lidocaine based gel for shingles pain and not it appears for post herpetic neuralgia as in the POH trial.

    The website information does make a distinction between its treatment and a patch treatment as follows.

    "Because the investigational gel is applied directly to the skin – without a patch – researchers believe it has the potential to be a flexible and convenient treatment option for people to use in the future".

    Come on POH (or Alyptus or whatever) get a wriggle on and get something happening or other trials and technologies may beat you to it!
 
watchlist Created with Sketch. Add AVE (ASX) to my watchlist
(20min delay)
Last
0.3¢
Change
0.001(50.0%)
Mkt cap ! $9.507M
Open High Low Value Volume
0.3¢ 0.3¢ 0.3¢ $7.267K 2.422M

Buyers (Bids)

No. Vol. Price($)
22 36992474 0.2¢
 

Sellers (Offers)

Price($) Vol. No.
0.3¢ 38389117 28
View Market Depth
Last trade - 15.43pm 11/11/2024 (20 minute delay) ?
AVE (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.